NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer

Citation
R. Casella et al., NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer, J UROL, 162(2), 1999, pp. 500-501
Citations number
4
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF UROLOGY
ISSN journal
00225347 → ACNP
Volume
162
Issue
2
Year of publication
1999
Pages
500 - 501
Database
ISI
SICI code
0022-5347(199908)162:2<500:NIASCT>2.0.ZU;2-#